← back to search

Scott J. Sherman

University of Arizona · US
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research focused on Parkinson's disease and Electroacupuncture, with related work in Gait, Neurotrophic factors, Antiepileptic drug. Notable publications include 'Effects of fetal antiepileptic drug exposure', 'Motor Performance Assessment in Parkinson’s Disease: Association between Objective In-Clinic, Objective In-Home, and Subjective/Semi-Objective Measures', and 'Parkinson's Disease Skin Fibroblasts Display Signature Alterations in Growth, Redox Homeostasis, Mitochondrial Function, and Autophagy'.
h-index
citations
930
works
19
NIH funding
primary concept
email

Recent publications

Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model
Neuropharmacology 2024cited by 9position: middledoi
Wearable Sensor-Based Chronic Condition Severity Assessment: An Adversarial Attention-Based Deep Multisource Multitask Learning Approach
MIS Quarterly 2022cited by 22position: middledoi
Fall Detection with Wearable Sensors: A Hierarchical Attention-based Convolutional Neural Network Approach
Journal of Management Information Systems 2021cited by 37position: middledoi
Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine
Experimental Neurology 2021cited by 25position: middledoi
Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT
Tomography 2021cited by 21position: middledoi
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia
Experimental Neurology 2020cited by 37position: middledoi
Parkinson's Disease Skin Fibroblasts Display Signature Alterations in Growth, Redox Homeostasis, Mitochondrial Function, and Autophagy
Frontiers in Neuroscience 2018cited by 70position: middledoi
Ten-Hour Exposure to Low-Dose Ketamine Enhances Corticostriatal Cross-Frequency Coupling and Hippocampal Broad-Band Gamma Oscillations
Frontiers in Neural Circuits 2018cited by 46position: middledoi
Alteration of Diffusion-Tensor Magnetic Resonance Imaging Measures in Brain Regions Involved in Early Stages of Parkinson's Disease
Brain Connectivity 2018cited by 34position: middledoi
The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced l-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia
Neuropharmacology 2018cited by 24position: middledoi
A Pilot Clinical Trial to Objectively Assess the Efficacy of Electroacupuncture on Gait in Patients with Parkinson's Disease Using Body Worn Sensors
PLoS ONE 2016cited by 64position: middledoi
Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing <smlcap>L</smlcap>-DOPA-Induced Dyskinesias
Case Reports in Neurology 2016cited by 33position: firstdoi
Motor Performance Assessment in Parkinson’s Disease: Association between Objective In-Clinic, Objective In-Home, and Subjective/Semi-Objective Measures
PLoS ONE 2015cited by 123position: middledoi
Long-term effect of sub-anesthetic ketamine in reducing l -DOPA-induced dyskinesias in a preclinical model
Neuroscience Letters 2015cited by 35position: middledoi
The Subthalamic Nucleus Contributes to Post-error Slowing
Journal of Cognitive Neuroscience 2014cited by 61position: middledoi
Does Integrative Medicine Enhance Balance in Aging Adults? Proof of Concept for the Benefit of Electroacupuncture Therapy in Parkinson's Disease
Gerontology 2014cited by 59position: middledoi
Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson’s disease
Neuroscience 2013cited by 54position: middledoi
Effects of fetal antiepileptic drug exposure
Neurology 2012cited by 132position: middledoi
PEDF and VEGF-A Output from Human Retinal Pigment Epithelial Cells Grown on Novel Microcarriers
Journal of Biomedicine and Biotechnology 2012cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Torsten Falk · University of Arizona9 papers (2012–2024)Mitchell J. Bartlett · University of Arizona7 papers (2013–2024)Michael L. Heien · University of Arizona4 papers (2015–2024)Hong Lei · University of Arizona4 papers (2014–2021)Tony Ye · UCLA Health3 papers (2018–2021)Nima Toosizadeh · Rutgers, The State University of New Jersey3 papers (2014–2016)Bijan Najafi · Baylor College of Medicine3 papers (2014–2016)Stephen L. Cowen · University of Arizona3 papers (2018–2021)Andrew J. Flores · UC San Diego Health System3 papers (2018–2020)Kate L. Parent · University of Arizona3 papers (2015–2020)Michael Schwenk · University of Konstanz2 papers (2014–2016)Shuo Yu · University of Arizona2 papers (2021–2022)Miguel Estevez · University of Arizona2 papers (2015–2016)Esther Sternberg · University of Arizona2 papers (2014–2016)Jane Mohler · University of Arizona2 papers (2014–2015)Alexander D. McCourt · University of Arizona1 papers (2012–2012)Adam Bernstein · University of Arizona1 papers (2018–2018)Lalitha Madhavan · University of Arizona1 papers (2018–2018)Robin Polt · University of Arizona1 papers (2018–2018)Drew C. Farrell · University of Arizona1 papers (2020–2020)